Artesunate
- Generic Name
- Artesunate
- Brand Names
- Artesunate Amivas
- Drug Type
- Small Molecule
- Chemical Formula
- C19H28O8
- CAS Number
- 88495-63-0
- Unique Ingredient Identifier
- 60W3249T9M
- Background
Artesunate is indicated for the initial treatment of severe malaria. The World Health Organization recommends artesunate as first line treatment for severe malaria. Artesunate was developed out of a need for a more hydrophilic derivative of artemisinin.
Artesunate was granted FDA approval on 26 May 2020.
- Indication
Artesunate is indicated for the initial treatment of severe malaria in adult and pediatric patients.
- Associated Conditions
- Acute Uncomplicated Plasmodium Falciparum Malaria, Malaria, Cerebral, Severe Malaria
- Associated Therapies
- -
Safety and Efficacy Study of IV Artesunate to Treat Malaria
- First Posted Date
- 2006-03-02
- Last Posted Date
- 2019-10-01
- Target Recruit Count
- 30
- Registration Number
- NCT00298610
- Locations
- 🇰🇪
New Nyanza Provincial Hospital, Kisumu, New Nyanza, Kenya
Efficacy and Safety of Azithromycin and Artesunate in Pregnant Women
- Conditions
- First Posted Date
- 2006-02-06
- Last Posted Date
- 2006-02-06
- Lead Sponsor
- University of North Carolina
- Target Recruit Count
- 141
- Registration Number
- NCT00287300
- Locations
- 🇲🇼
Mpemba and Madziabango Health Centers, Blantyre, Malawi
Artesunate in Preemptive Treatment of Human Cytomegalovirus (CMV) in Stem Cell Transplant Recipients
- Conditions
- First Posted Date
- 2006-02-01
- Last Posted Date
- 2010-06-10
- Lead Sponsor
- Hadassah Medical Organization
- Target Recruit Count
- 20
- Registration Number
- NCT00284687
- Locations
- 🇮🇱
Hadassah Medical Organization, Jerusalem,, Israel
A Trial of Four Drug Regimens for the Prevention of Malaria in Senegalese Children
- Conditions
- First Posted Date
- 2005-08-22
- Last Posted Date
- 2017-01-12
- Lead Sponsor
- London School of Hygiene and Tropical Medicine
- Target Recruit Count
- 2200
- Registration Number
- NCT00132548
- Locations
- 🇸🇳
Institut de recherche pour le developpement, Dakar, Senegal
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.